Abstract
The adrenergic system is an essential regulator of neuronal, endocrine, cardiovascular, vegetative, and metabolic functions. The endogenous catecholamines epinephrine and norepinephrine activate G-protein-coupled receptors to transmit their signal across the plasma membrane. These adrenoceptors can be divided into three different groups: the α1-receptors (α1A, α1B, α1D), α2-receptors (α2A, α2B, α2C), and β-receptors (β1, β2, β3). This review summarizes recent findings in the field of adrenoceptor signaling in neurons and includes a discussion of receptor-associated proteins, receptor dimerization, subcellular trafficking, and fluorescence optical methods for studying the kinetics of adrenergic signaling. Spatio-temporal imaging may become an important future tool for identifying the physiological significance of these complex signaling mechanisms in vivo. Gene-targeted mouse models carrying deletions in α2-adrenoceptor have provided detailed insights into specific neuronal functions of the three α2-receptor subtypes.
Similar content being viewed by others
References
Agnati LF, Fuxe K, Zoli M, Rondanini C, Ogren SO (1982) New vistas on synaptic plasticity: the receptor mosaic hypothesis of the engram. Med Biol 60:183–190
Ahlquist RP (1948) A study of the adrenotropic receptors. Am J Physiol 153:586–600
Altman JD, Trendelenburg AU, MacMillan L, Bernstein D, Limbird L, Starke K, Kobilka BK, Hein L (1999) Abnormal regulation of the sympathetic nervous system in α2A-adrenergic receptor knockout mice. Mol Pharmacol 56:154–161
Angers S, Salahpour A, Joly E, Hilairet S, Chelsky D, Dennis M, Bouvier M (2000) Detection of β2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci USA 97:3684–3689
Angers S, Salahpour A, Bouvier M (2002) Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu Rev Pharmacol Toxicol 42:409–435
Bjorklund M, Siverina I, Heikkinen T, Tanila H, Sallinen J, Scheinin M, Riekkinen P Jr (2001) Spatial working memory improvement by an α2-adrenoceptor agonist dexmedetomidine is not mediated through α2C-adrenoceptor. Prog Neuropsychopharmacol Biol Psychiatry 25:1539–1554
Brady AE, Wang Q, Allen PB, Rizzo M, Greengard P, Limbird LE (2005) α2-Adrenergic agonist enrichment of spinophilin at the cell surface involves βγ subunits of Gi proteins and is preferentially induced by the α2A-subtype. Mol Pharmacol 67:1690–1696
Brede M, Nagy G, Philipp M, Sorensen JB, Lohse MJ, Hein L (2003a) Differential control of adrenal and sympathetic catecholamine release by α2-adrenoceptor subtypes. Mol Endocrinol 17:1640–1646
Brede M, Roell W, Ritter O, Wiesmann F, Jahns R, Haase A, Fleischmann BK, Hein L (2003b) Cardiac hypertrophy is associated with decreased eNOS expression in angiotensin AT2 receptor-deficient mice. Hypertension 42:1177–1182
Brede M, Philipp M, Knaus A, Muthig V, Hein L (2004) α2-Adrenergic receptor subtypes—novel functions uncovered in gene-targeted mouse models. Biol Cell 96:343–348
Breit A, Lagace M, Bouvier M (2004) Hetero-oligomerization between β2- and β3-adrenergic receptors generates a β-adrenergic signaling unit with distinct functional properties. J Biol Chem 279:28756–28765
Bücheler M, Hadamek K, Hein L (2002) Two α2-adrenergic receptor subtypes, α2A and α2C, inhibit transmitter release in the brain of gene-targeted mice. Neuroscience 109:819–826
Bünemann M, Frank M, Lohse MJ (2003) Gi protein activation in intact cells involves subunit rearrangement rather than dissociation. Proc Natl Acad Sci USA 100:16077–16082
Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR Jr, Trendelenburg U (1994) International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev 46:121–136
Carson RP, Robertson D (2002) Genetic manipulation of noradrenergic neurons. J Pharmacol Exp Ther 301:410–417
Cavalli A, Lattion AL et al (1997) Decreased blood pressure response in mice deficient of the α1B-adrenergic receptor. Proc Natl Acad Sci USA 94:11589–11594
Chalothorn D, McCune DF, Edelmann SE, Garcia-Cazarin ML, Tsujimoto G, Piascik MT (2002) Differences in the cellular localization and agonist-mediated internalization properties of the α1-adrenoceptor subtypes. Mol Pharmacol 61:1008–1016
Chruscinski AJ, Rohrer DK, Schauble E, Desai KH, Bernstein D, Kobilka BK (1999) Targeted disruption of the β2 adrenergic receptor gene. J Biol Chem 274:16694–16700
Cussac D, Schaak S, Gales C, Flordellis C, Denis C, Paris H (2001) α2B-Adrenergic receptors activate MAPK and modulate the proliferation of primary cultured proximal tubule cells. Am J Physiol Renal Physiol 8:8
Daunt DA, Hurt C, Hein L, Kallio J, Feng F, Kobilka BK (1997) Subtype-specific intracellular trafficking of α2-adrenergic receptors. Mol Pharmacol 51:711–720
DeGraff JL, Gagnon AW, Benovic JL, Orsini MJ (1999) Role of arrestins in endocytosis and signaling of α2-adrenergic receptor subtypes. J Biol Chem 274:11253–11259
Dixon RA, Kobilka BK, Strader DJ, Benovic JL, Dohlman HG, Frielle T, Bolanowski MA, Bennett CD, Rands E, Diehl RE et al (1986) Cloning of the gene and cDNA for mammalian β-adrenergic receptor and homology with rhodopsin. Nature 321:75–79
Drouin C, Darracq L, Trovero F, Blanc G, Glowinski J, Cotecchia S, Tassin JP (2002) α1B-Adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates. J Neurosci 22:2873–2884
Fairbanks CA, Wilcox GL (1999) Moxonidine, a selective α2-adrenergic and imidazoline receptor agonist, produces spinal antinociception in mice. J Pharmacol Exp Ther 290:403–412
Fairbanks CA, Stone LS, Kitto KF, Nguyen HO, Posthumus IJ, Wilcox GL (2002) α2C-Adrenergic receptors mediate spinal analgesia and adrenergic-opioid synergy. J Pharmacol Exp Ther 300:282–290
Foote SL, Bloom FE, Aston-Jones G (1983) Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiol Rev 63:844–914
Frank M, Thumer L, Lohse MJ, Bunemann M (2005) G protein activation without subunit dissociation depends on a Gαi-specific region. J Biol Chem 280:24584–24590
Gainetdinov RR, Caron MG (2003) Monoamine transporters: from genes to behavior. Annu Rev Pharmacol Toxicol 43:261–284
Gainetdinov RR, Premont RT, Bohn LM, Lefkowitz RJ, Caron MG (2004) Desensitization of G protein-coupled receptors and neuronal functions. Annu Rev Neurosci 27:107–144
Hague C, Uberti MA, Chen Z, Hall RA, Minneman KP (2004) Cell surface expression of α1D-adrenergic receptors is controlled by heterodimerization with α1B-adrenergic receptors. J Biol Chem 279:15541–15549
Hebert TE, Moffett S, Morello JP, Loisel TP, Bichet DG, Barret C, Bouvier M (1996) A peptide derived from a β2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem 271:16384–16392
Hein L, Altman JD, Kobilka BK (1999) Two functionally distinct α2-adrenergic receptors regulate sympathetic neurotransmission. Nature 402:181–184
Hoffmann BB, Lefkowitz RJ (1996) Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Hardman JG, Limbird LE (eds) Goodman & Gilman’s pharmacological basis of therapeutics. McGraw-Hill, New York, pp 199–248
Hunter JC, Fontana DJ, Hedley LR, Jasper JR, Lewis R, Link RE, Secchi R, Sutton J, Eglen RM (1997) Assessment of the role of α2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice. Br J Pharmacol 122:1339–1344
Hurt CM, Feng FY, Kobilka B (2000) Cell-type specific targeting of the α2C-adrenoceptor. Evidence for the organization of receptor microdomains during neuronal differentiation of PC12 cells. J Biol Chem 275:35424–35431
Janumpalli S, Butler LS, MacMillan LB, Limbird LE, McNamara JO (1998) A point mutation (D79N) of the α2A adrenergic receptor abolishes the antiepileptogenic action of endogenous norepinephrine. J Neurosci 18:2004–2008
Kawasaki Y, Kumamoto E, Furue H, Yoshimura M (2003) α2 Adrenoceptor-mediated presynaptic inhibition of primary afferent glutamatergic transmission in rat substantia gelatinosa neurons. Anesthesiology 98:682–689
Kingery WS, Agashe GS, Guo TZ, Sawamura S, Frances Davies M, David Clark J, Kobilka BK, Maze M (2002) Isoflurane and nociception: spinal α2A adrenoceptors mediate antinociception while supraspinal α1 adrenoceptors mediate pronociception. Anesthesiology 96:367–374
Kobilka BK, Matsui H, Kobilka TS, Yang-Feng TL, Francke U, Caron MG, Lefkowitz RJ, Regan JW (1987) Cloning, sequencing, and expression of the gene coding for the human platelet α2-adrenergic receptor. Science 238:650–656
Lahdesmaki J, Sallinen J, MacDonald E, Scheinin M (2004) α2A-Adrenoceptors are important modulators of the effects of D-amphetamine on startle reactivity and brain monoamines. Neuropsychopharmacology 29:1282–1293
Lakhlani PP, MacMillan LB, Guo TZ, McCool BA, Lovinger DM, Maze M, Limbird LE (1997) Substitution of a mutant α2A-adrenergic receptor via “hit and run” gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo. Proc Natl Acad Sci USA 94:9950–9955
Lavoie C, Mercier JF, Salahpour A, Umapathy D, Breit A, Villeneuve LR, Zhu WZ, Xiao RP, Lakatta EG, Bouvier M, Hebert TE (2002) β1/β2-Adrenergic receptor heterodimerization regulates β2-adrenergic receptor internalization and ERK signaling efficacy. J Biol Chem 277:35402–35410
Lefkowitz RJ, Shenoy SK (2005) Transduction of receptor signals by β-arrestins. Science 308:512–517
Link RE, Stevens MS, Kulatunga M, Scheinin M, Barsh GS, Kobilka BK (1995) Targeted inactivation of the gene encoding the mouse α2C-adrenoceptor homolog. Mol Pharmacol 48:48–55
Link RE, Desai K, Hein L, Stevens ME, Chruscinski A, Bernstein D, Barsh GS, Kobilka BK (1996) Cardiovascular regulation in mice lacking α2-adrenergic receptor subtypes b and c. Science 273:803–805
Ma D, Hossain M, Rajakumaraswamy N, Arshad M, Sanders RD, Franks NP, Maze M (2004a) Dexmedetomidine produces its neuroprotective effect via the α2A-adrenoceptor subtype. Eur J Pharmacol 502:87–97
Ma D, Rajakumaraswamy N, Maze M (2004b) α2-Adrenoceptor agonists: shedding light on neuroprotection? Br Med Bull 71:77–92
MacDonald E, Kobilka BK, Scheinin M (1997) Gene targeting—homing in on α2-adrenoceptor-subtype function. Trends Pharmacol Sci 18:211–219
MacMillan LB, Hein L, Smith MS, Piascik MT, Limbird LE (1996) Central hypotensive effects of the α2A-adrenergic receptor subtype. Science 273:801–803
MacMillan LB, Lakhlani PP, Hein L, Piascik M, Guo TZ, Lovinger D, Maze M, Limbird LE (1998) In vivo mutation of the α2A-adrenergic receptor by homologous recombination reveals the role of this receptor subtype in multiple physiological processes. Adv Pharmacol 42:493–496
Mercier JF, Salahpour A, Angers S, Breit A, Bouvier M (2002) Quantitative assessment of β1- and β2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. J Biol Chem 277:44925–44931
Miller RJ (1998) Presynaptic receptors. Annu Rev Pharmacol Toxicol 38:201–227
Murchison CF, Zhang XY, Zhang WP, Ouyang M, Lee A, Thomas SA (2004) A distinct role for norepinephrine in memory retrieval. Cell 117:131–143
Nicholas AP, Hokfelt T, Pieribone VA (1996) The distribution and significance of CNS adrenoceptors examined with in situ hybridization. Trends Pharmacol Sci 17:245–255
Nikolaev VO, Bunemann M, Hein L, Hannawacker A, Lohse MJ (2004) Novel single chain cAMP sensors for receptor-induced signal propagation. J Biol Chem 279:37215–37218
Olli-Lahdesmaki T, Kallio J, Scheinin M (1999) Receptor subtype-induced targeting and subtype-specific internalization of human α2-adrenoceptors in PC12 cells. J Neurosci 19:9281–9288
Olli-Lahdesmaki T, Scheinin M, Pohjanoksa K, Kallio J (2003) Agonist-dependent trafficking of α2-adrenoceptor subtypes: dependence on receptor subtype and employed agonist. Eur J Cell Biol 82:231–239
Paris A, Philipp M, Tonner PH, Steinfath M, Lohse M, Scholz J, Hein L (2003) Activation of α2B-adrenoceptors mediates the cardiovascular effects of etomidate. Anesthesiology 99:889–895
Paris A, Mantz J, Tonner PH, Hein L, Brede M, Gressens P (2006) The effects of dexmedetomidine on perinatal excitotoxic brain injury are mediated by the α2A-adrenoceptor subtype. Anesth Analg 102:456–461
Philipp M, Hein L (2004) Adrenergic receptor knockout mice: distinct functions of 9 receptor subtypes. Pharmacol Ther 101:65–74
Philipp M, Brede M, Hadamek K, Gessler M, Lohse MJ, Hein L (2002a) Placental α2-adrenoceptors control vascular development at the interface between mother and embryo. Nat Genet 31:311–315
Philipp M, Brede M, Hein L (2002b) Physiological significance of α2-adrenergic receptor subtype diversity: one receptor is not enough. Am J Physiol Regul Integr Comp Physiol 283:R287–R295
Prinster SC, Hague C, Hall RA (2005) Heterodimerization of g protein-coupled receptors: specificity and functional significance. Pharmacol Rev 57:289–298
Rohrer DK (1998) Physiological consequences of β-adrenergic receptor disruption. J Mol Med 76:764–772
Rohrer DK, Kobilka BK (1998) G protein-coupled receptors: functional and mechanistic insights through altered gene expression. Physiol Rev 78:35–52
Rohrer DK, Desai KH, Jasper JR, Stevens ME, Regula DP Jr, Barsh GS, Bernstein D, Kobilka BK (1996) Targeted disruption of the mouse β2-adrenergic receptor gene: developmental and cardiovascular effects. Proc Natl Acad Sci USA 93:7375–7380
Rokosh DG, Simpson PC (2002) Knockout of the α1A/C-adrenergic receptor subtype: the α1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure. Proc Natl Acad Sci USA 99:9474–9479
Salahpour A, Angers S, Mercier JF, Lagace M, Marullo S, Bouvier M (2004) Homodimerization of the β2-adrenergic receptor as a prerequisite for cell surface targeting. J Biol Chem 279:33390–33397
Sallinen J, Haapalinna A, Viitamaa T, Kobilka BK, Scheinin M (1998) D-amphetamine and L-5-hydroxytryptophan-induced behaviours in mice with genetically-altered expression of the α2C-adrenergic receptor subtype. Neuroscience 86:959–965
Saunders C, Limbird LE (1999) Localization and trafficking of α2-adrenergic receptor subtypes in cells and tissues. Pharmacol Ther 84:193–205
Sawamura S, Kingery WS, Davies MF, Agashe GS, Clark JD, Kobilka BK, Hashimoto T, Maze M (2000) Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of α2B adrenoceptors. J Neurosci 20:9242–9251
Scheibner J, Trendelenburg AU, Hein L, Starke K (2001) α2-Adrenoceptors modulating neuronal serotonin release: a study in α2-adrenoceptor subtype-deficient mice. Br J Pharmacol 132:925–933
Scheinin M, Sallinen J, Haapalinna A (2001) Evaluation of the α2C-adrenoceptor as a neuropsychiatric drug target studies in transgenic mouse models. Life Sci 68:2277–2285
Simonneaux V, Ribelayga C (2003) Generation of the melatonin endocrine message in mammals: a review of the complex regulation of melatonin synthesis by norepinephrine, peptides, and other pineal transmitters. Pharmacol Rev 55:325–395
Small KM, Schwarb MR, Glinka C, Theiss CT, Brown KM, Seman CA, Liggett SB (2006) α2A- and α2C-adrenergic receptors form homo- and heterodimers: the heterodimeric state impairs agonist-promoted GRK phosphorylation and β-arrestin recruitment. Biochemistry 45:4760–4767
Spreng M, Cotecchia S, Schenk F (2001) A behavioral study of α1B adrenergic receptor knockout mice: increased reaction to novelty and selectively reduced learning capacities. Neurobiol Learn Mem 75:214–229
Stephens GJ, Mochida S (2005) G protein βγ subunits mediate presynaptic inhibition of transmitter release from rat superior cervical ganglion neurones in culture. J Physiol (Lond) 563:765–776
Stone LS, MacMillan LB, Kitto KF, Limbird LE, Wilcox GL (1997) The α2A adrenergic receptor subtype mediates spinal analgesia evoked by α2 agonists and is necessary for spinal adrenergic-opioid synergy. J Neurosci 17:7157–7165
Surprenant A, Horstman DA, Akbarali H, Limbird LE (1992) A point mutation of the α2-adrenoceptor that blocks coupling to potassium but not calcium currents. Science 257:977–980
Susulic VS, Frederich RC, Lawitts J, Tozzo E, Kahn BB, Harper ME, Himms-Hagen J, Flier JS, Lowell BB (1995) Targeted disruption of the β3-adrenergic receptor gene. J Biol Chem 270:29483–29492
Tanoue A, Nasa Y, Koshimizu T, Shinoura H, Oshikawa S, Kawai T, Sunada S, Takeo S, Tsujimoto G (2002) The α1D-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction. J Clin Invest 109:765–775
Torres GE, Gainetdinov RR, Caron MG (2003) Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci 4:13–25
Trendelenburg AU, Cox SL, Schelb V, Klebroff W, Khairallah L, Starke K (2000) Modulation of 3H-noradrenaline release by presynaptic opioid, cannabinoid and bradykinin receptors and β-adrenoceptors in mouse tissues. Br J Pharmacol 130:321–330
Trendelenburg AU, Philipp M, Meyer A, Klebroff W, Hein L, Starke K (2003) All three α2-adrenoceptor types serve as autoreceptors in postganglionic sympathetic neurons. Naunyn-Schmiedeberg’s Arch Pharmacol 368:504–512
Uberti MA, Hall RA, Minneman KP (2003) Subtype-specific dimerization of α1-adrenoceptors: effects on receptor expression and pharmacological properties. Mol Pharmacol 64:1379–1390
Vilardaga JP, Bunemann M, Krasel C, Castro M, Lohse MJ (2003) Measurement of the millisecond activation switch of G protein-coupled receptors in living cells. Nat Biotechnol 21:807–812
Wang BH, Du XJ, Autelitano DJ, Milano CA, Woodcock EA (2000) Adverse effects of constitutively active α1B-adrenergic receptors after pressure overload in mouse hearts. Am J Physiol Heart Circ Physiol 279:H1079–H1086
Weber B, Schaper C, Scholz J, Bein B, Rodde C, Tonner PH (2006) Interaction of the amyloid precursor like protein 1 with the α2A-adrenergic receptor increases agonist-mediated inhibition of adenylyl cyclase. Cell Signal March 9, Epub ahead of print
Wettschureck N, Offermanns S (2005) Mammalian G proteins and their cell type specific functions. Physiol Rev 85:1159–1204
Winder DG, Martin KC, Muzzio IA, Rohrer D, Chruscinski A, Kobilka B, Kandel ER (1999) ERK plays a regulatory role in induction of LTP by theta frequency stimulation and its modulation by β-adrenergic receptors. Neuron 24:715–726
Wozniak M, Limbird LE (1998) Trafficking itineraries of G protein-coupled receptors in epithelial cells do not predict receptor localization in neurons. Brain Res 780:311–322
Wu LG, Saggau P (1997) Presynaptic inhibition of elicited neurotransmitter release. Trends Neurosci 20:204–212
Yudowski GA, Puthenveedu MA, Zastrow M von (2006) Distinct modes of regulated receptor insertion to the somatodendritic plasma membrane. Nat Neurosci 9:622–627
Zastrow M von, Link R, Daunt D, Barsh G, Kobilka B (1993) Subtype-specific differences in the intracellular sorting of G protein-coupled receptors. J Biol Chem 268:763–766
Zuscik MJ, Sands S, Ross SA, Waugh DJ, Gaivin RJ, Morilak D, Perez DM (2000) Overexpression of the α1B-adrenergic receptor causes apoptotic neurodegeneration: multiple system atrophy. Nat Med 6:1388–1394
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hein, L. Adrenoceptors and signal transduction in neurons. Cell Tissue Res 326, 541–551 (2006). https://doi.org/10.1007/s00441-006-0285-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00441-006-0285-2